Prognostic Value of Lactates in ICU

Mongi Slim Hospital

Status: Completed

Conditions: Mortality

Treatments: Diagnostic Test: Blood lactate level

Study type: Observational

Funder types: Other

Identifiers

NCT04792736

Lactates ICU

Details and patient eligibility

About

he aim of this prospective, analytic trial was to evaluate the accuracy of blood lactates levels in predicting mortality in ICU patients.

Full description

In this study, conducted over o 12 months period, arterial blood lactates levels were measured in ICU patients at admission (H0), every 6 hours during the first day and and H48.

This trial included traumatic, medical and surgical patients requiring ICU stay for a predictive period > to 24 hours.

Blood lactates were evaluated as a prognostic parameter in predicting ICU mortality and compared to classic prognostic scores such as: SOFA score, IGS II and APACHE II.

The primary end point was ICU mortality.

Enrollment: 135 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All adults admissions in ICU with a predicted length of stay > 24 hours

Exclusion criteria

• Patients who died during the first 24 hours after ICU admission

Trial design

135 participants in 2 patient groups

Survivors

Description:

Patients discharged alive from intensive care unit

Treatment:

Diagnostic Test: Blood lactate level

non survivors

Description:

Patients who succumbed during their ICU stay

Treatment:

Diagnostic Test: Blood lactate level